<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cockayne" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cockayne</book-part-id>
      <title-group>
        <title>Cockayne Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Laugel</surname>
            <given-names>Vincent</given-names>
          </name>
          <xref ref-type="aff" rid="cockayne.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>Vincent.laugel@chru-strasbourg.fr</email>
        </contrib>
      </contrib-group>
      <aff id="cockayne.AFF1">Laboratory of Medical Genetics<break/>Strasbourg, France</aff>
      <pub-history>
        <date iso-8601-date="2000-12-28" date-type="created">
          <day>28</day>
          <month>12</month>
          <year>2000</year>
        </date>
        <date iso-8601-date="2012-06-14" date-type="updated">
          <day>14</day>
          <month>06</month>
          <year>2012</year>
        </date>
        <date iso-8601-date="2003-09-24" date-type="revised">
          <day>24</day>
          <month>9</month>
          <year>2003</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ccd" document-type="chapter">Cleidocranial Dysplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cls" document-type="chapter">Coffin-Lowry Syndrome</related-object>
      <abstract id="cockayne.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Cockayne syndrome (referred to as CS in this <italic toggle="yes">GeneReview</italic>) spans a phenotypic spectrum that includes: </p>
          <list list-type="bullet">
            <list-item>
              <p>CS type I, the "classic" or &#x0201c;moderate&#x0201d; form; </p>
            </list-item>
            <list-item>
              <p>CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal syndrome (COFS) or Pena-Shokeir syndrome type II; </p>
            </list-item>
            <list-item>
              <p>CS type III, a milder form; </p>
            </list-item>
            <list-item>
              <p>Xeroderma pigmentosum-Cockayne syndrome (XP-CS). </p>
            </list-item>
          </list>
          <p>CS type I (moderate CS) is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. </p>
          <p>CS type II (severe CS or early-onset CS) is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age seven years. </p>
          <p>CS type III (mild CS or late-onset CS) is characterized by essentially normal growth and cognitive development or by late onset. </p>
          <p>Xeroderma pigmentosum-Cockayne syndrome (XP-CS) includes facial freckling and early skin cancers typical of XP and some features typical of CS, including intellectual disability, spasticity, short stature, and hypogonadism. XP-CS does not include skeletal involvement, the facial phenotype of CS, or CNS dysmyelination and calcifications. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Classic Cockayne syndrome (CS) is diagnosed by clinical findings including postnatal growth failure and progressive neurologic dysfunction along with other minor criteria. Molecular genetic testing or a specific DNA repair assay on fibroblasts can confirm the diagnosis. The two genes in which mutations are known to cause Cockayne syndrome are <italic toggle="yes">ERCC6</italic> (65% of individuals) and <italic toggle="yes">ERCC8</italic> (35% of individuals). </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Individualized educational programs for developmental delay; physical therapy to maintain ambulation; gastrostomy tube placement as needed; medications for spasticity and tremor as needed; use of sunscreens and sunglasses for cutaneous photosensitivity and lens/retina protection, respectively; treatment of hearing loss, cataracts, and other ophthalmologic complications as in the general population. </p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Physical therapy to prevent joint contractures; aggressive dental care to minimize dental caries; home safety assessment to prevent falls.</p>
          <p><italic toggle="yes">Surveillance</italic>: Yearly assessment for complications such as hypertension, renal or hepatic dysfunction, and declining vision and hearing. </p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Excessive sun exposure.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Cockayne syndrome is inherited in an autosomal recessive manner. Both parents of an affected child are obligate carriers of an abnormal gene. Heterozygotes are asymptomatic. Each sib of a proband has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Reproduction does not occur in CS types I and II. Carrier detection for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the disease-causing mutations in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cockayne.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cockayne.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Cockayne syndrome (CS) is characterized by growth failure and multisystemic degeneration, with a variable age of onset and rate of progression. The phenotypic spectrum of CS can be divided into three general clinical presentations: </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cockayne syndrome type I.</bold> "Classic" CS in which the major features of the disease become apparent by age one to two years</p>
            </list-item>
            <list-item>
              <p><bold>Cockayne syndrome type II.</bold> A more severe form with abnormalities recognized at birth or in the early neonatal period </p>
            </list-item>
            <list-item>
              <p><bold>Cockayne syndrome type III.</bold> Milder/later-onset forms that are still poorly defined </p>
            </list-item>
          </list>
          <p>Formal clinical diagnostic criteria have been proposed only for CS type I [<xref ref-type="bibr" rid="cockayne.REF.nance.1992.68">Nance &#x00026; Berry 1992</xref>]. Because of the progressive nature of CS, the clinical diagnosis of CS becomes more certain as additional signs and symptoms gradually manifest over time. </p>
          <p>At all stages of disease progression, molecular genetic testing can be useful for confirming the suspected clinical diagnosis. </p>
          <sec id="cockayne.Classic_Cockayne_Syndrome_CS_Ty">
            <title>Classic Cockayne Syndrome (CS Type I) </title>
            <p>CS type I is suspected: </p>
            <list list-type="bullet">
              <list-item>
                <p>In an older child when both major criteria are present and three minor criteria are present; </p>
              </list-item>
              <list-item>
                <p>In an infant or toddler when both major criteria are present, especially if there is increased cutaneous photosensitivity. </p>
              </list-item>
            </list>
            <p>
              <bold>Major criteria</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Postnatal growth failure (height and weight &#x0003c;5th centile by age 2 years) </p>
              </list-item>
              <list-item>
                <p>Progressive microcephaly and neurologic dysfunction manifested as early developmental delay in most individuals, followed by progressive behavioral and intellectual deterioration in all individuals; brain MRI reveals leukodystrophy [<xref ref-type="bibr" rid="cockayne.REF.boltshauser.1989.276">Boltshauser et al 1989</xref>, <xref ref-type="bibr" rid="cockayne.REF.sugita.1992.295">Sugita et al 1992</xref>]. Intracranial calcifications are seen in some individuals. </p>
              </list-item>
            </list>
            <p>
              <bold>Minor criteria</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Cutaneous photosensitivity with or without thin or dry skin or hair (~75%) </p>
              </list-item>
              <list-item>
                <p>Demyelinating peripheral neuropathy diagnosed by electromyography, nerve conduction testing, and/or nerve biopsy </p>
              </list-item>
              <list-item>
                <p>Pigmentary retinopathy (~55%) and/or cataracts (~36%) </p>
              </list-item>
              <list-item>
                <p>Sensorineural hearing loss (~60%) </p>
              </list-item>
              <list-item>
                <p>Dental anomalies, including dental caries (~86%), enamel hypoplasia, anomalies of tooth number and anomalies of tooth size and shape </p>
              </list-item>
              <list-item>
                <p>A characteristic physical appearance of "cachectic dwarfism" with thinning of the skin and hair, sunken eyes, and a stooped standing posture </p>
              </list-item>
              <list-item>
                <p>Characteristic radiographic findings of thickening of the calvarium, sclerotic epiphyses, vertebral and pelvic abnormalities </p>
              </list-item>
            </list>
            <p><bold>Family history.</bold> The presence of a similarly affected sib can be useful for diagnosis. </p>
          </sec>
          <sec id="cockayne.Severe_Cockayne_Syndrome_CS_Typ">
            <title>Severe Cockayne Syndrome (CS Type II) </title>
            <p>CS type II is suspected: </p>
            <list list-type="bullet">
              <list-item>
                <p>In infants with growth failure at birth and little postnatal increase in height, weight, or head circumference; </p>
              </list-item>
              <list-item>
                <p>When there is little or no postnatal neurologic development;</p>
              </list-item>
              <list-item>
                <p>When congenital cataracts as well as other structural defects of the eye (microphthalmos, microcornea, iris hypoplasia) are present. </p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="cockayne.Testing">
          <title>Testing</title>
          <p><bold>Assay of cellular phenotype</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>DNA repair assay.</bold> Assays of DNA repair are performed on skin fibroblasts. The most consistent findings in CS fibroblasts are: marked sensitivity to UV radiation; deficient recovery of RNA synthesis following UV damage; and impaired repair of actively transcribed genes, or "transcription-coupled repair" [<xref ref-type="bibr" rid="cockayne.REF.venema.1990.4707">Venema et al 1990</xref>, <xref ref-type="bibr" rid="cockayne.REF.troelstra.1992.939">Troelstra et al 1992</xref>, <xref ref-type="bibr" rid="cockayne.REF.vangool.1997.5955">van Gool et al 1997</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold>Complementation groups.</bold> Cells from individuals with CS can be divided into two complementation groups based on the protein that corrects the DNA repair defect: (1) the DNA excision repair protein ERCC-8 (formerly known as CS WD-repeat protein) in Cockayne syndrome-A (CSA) (25% of individuals) and (2) the DNA excision repair protein ERCC-6 in Cockayne syndrome-B (CSB) (75% of individuals) [<xref ref-type="bibr" rid="cockayne.REF.stefanini.1996.418">Stefanini et al 1996</xref>]. </p>
            </list-item>
          </list>
          <sec id="cockayne.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Mutations in two genesare known to cause Cockayne syndrome: </p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">ERCC6</italic></bold>. Mutations in <italic toggle="yes">ERCC6</italic> cause Cockayne syndrome complementation group type B (CSB), which accounts for 65% of cases [<xref ref-type="bibr" rid="cockayne.REF.troelstra.1992.939">Troelstra et al 1992</xref>, <xref ref-type="bibr" rid="cockayne.REF.troelstra.1993.419">Troelstra et al 1993</xref>]. </p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">ERCC8</italic></bold> (previously known as <italic toggle="yes">CKN1</italic>). Mutations in <italic toggle="yes">ERCC8</italic> cause Cockayne syndrome complementation group type A (CSA), which accounts for 35% of cases [<xref ref-type="bibr" rid="cockayne.REF.henning.1995.555">Henning et al 1995</xref>]. </p>
              </list-item>
            </list>
            <p>Most variants can be detected by DNA sequence analysis of the coding and flanking intronic regions of the genes. Deletion/duplication analysis and/or sequencing of the cDNA can detect additional variants in a minority of cases. <xref ref-type="table" rid="cockayne.T.summary_of_types_of_pathogeni">Table 2</xref> summarizes the type of mutations. </p>
            <table-wrap id="cockayne.T.summary_of_molecular_genetic_" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Cockayne Syndrome</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_2" align="left" valign="top" rowspan="1" colspan="1">% of CS Attributed to Mutations in This Gene</th>
                    <th id="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                  </tr>
                  <tr>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                      <italic toggle="yes">ERCC8</italic>
                    </td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">~35% </td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>4,&#x000a0;5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Exonic or whole-gene deletions&#x000a0;<sup>4,&#x000a0;7</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                      <italic toggle="yes">ERCC6</italic>
                    </td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">~65% </td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>4,&#x000a0;5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_b_cockayne.T.summary_of_molecular_genetic__1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Exonic or whole-gene deletions&#x000a0;<sup>4,&#x000a0;7</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cockayne.TF.1">
                  <label>1.</label>
                  <p>See <related-object source-id="gene" document-id="cockayne" object-id="cockayne.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. </p>
                </fn>
                <fn id="cockayne.TF.1.1">
                  <label>2.</label>
                  <p>See <xref ref-type="sec" rid="cockayne.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="cockayne.TF.1.2">
                  <label>3.</label>
                  <p>Mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="cockayne.TF.1.3">
                  <label>4.</label>
                  <p>Pathogenic allelic variants reported in <italic toggle="yes">ERCC8</italic> and <italic toggle="yes">ERCC6</italic> are summarized in <xref ref-type="table" rid="cockayne.T.summary_of_types_of_pathogeni">Table 2</xref>.</p>
                </fn>
                <fn id="cockayne.TF.1.4">
                  <label>5.</label>
                  <p>A majority are nonsense or frameshift mutations that predict a truncated protein [<xref ref-type="bibr" rid="cockayne.REF.troelstra.1992.939">Troelstra et al 1992</xref>, <xref ref-type="bibr" rid="cockayne.REF.mallery.1998.77">Mallery et al 1998</xref>, <xref ref-type="bibr" rid="cockayne.REF.colella.1999.935">Colella et al 1999</xref>, <xref ref-type="bibr" rid="cockayne.REF.meira.2000.1221">Meira et al 2000</xref>, <xref ref-type="bibr" rid="cockayne.REF.horibata.2004.15410">Horibata et al 2004</xref>].</p>
                </fn>
                <fn id="cockayne.TF.1.5">
                  <label>6.</label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="cockayne.TF.1.6">
                  <label>7.</label>
                  <p>Exonic or whole-gene deletions of <italic toggle="yes">ERCC8</italic> escape detection by sequence analysis when present in a heterozygous state or compound heterozygous state [<xref ref-type="bibr" rid="cockayne.REF.henning.1995.555">Henning et al 1995</xref>, <xref ref-type="bibr" rid="cockayne.REF.ren.2003.93">Ren et al 2003</xref>, <xref ref-type="bibr" rid="cockayne.REF.cao.2004.61">Cao et al 2004</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="cockayne.Testing_Strategy">
          <title>Testing Strategy </title>
          <p>
            <bold>To establish the diagnosis in a proband involves molecular genetic testing&#x000a0;</bold>
            <sup>
              <bold>1</bold>
            </sup>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">ERCC6</italic>, followed by deletion/duplication analysis. If no <italic toggle="yes">ERCC6</italic> mutation is identified, sequence analysis of <italic toggle="yes">ERCC8</italic>, followed by deletion/duplication analysisOR</p>
            </list-item>
            <list-item>
              <p>Sequence analysis of <italic toggle="yes">ERCC6</italic>, followed by sequencing of <italic toggle="yes">ERCC8</italic>. If sequence analyses do not identify both mutations, deletion/duplication analysis of <italic toggle="yes">ERCC8</italic> and <italic toggle="yes">ERCC6.</italic>
</p>
            </list-item>
          </list>
          <p>1. Testing algorithms vary by clinic and laboratory.</p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="cockayne.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="cockayne.Natural_History">
          <title>Clinical Description</title>
          <p>Before the molecular genetics of Cockayne syndrome was understood, it was thought to have a single, discrete phenotype: classic Cockayne syndrome. It is now recognized that Cockayne syndrome spans a phenotypic spectrum that includes the following [<xref ref-type="bibr" rid="cockayne.REF.nance.1992.68">Nance &#x00026; Berry 1992</xref>]: </p>
          <list list-type="bullet">
            <list-item>
              <p>CS type I, the "classic" form [<xref ref-type="bibr" rid="cockayne.REF.lowry.1982.209">Lowry 1982</xref>] </p>
            </list-item>
            <list-item>
              <p>CS type II, a more severe form with symptoms present at birth (overlapping with cerebrooculofacioskeletal syndrome (COFS) and Pena-Shokeir type II syndrome)</p>
            </list-item>
            <list-item>
              <p>CS type III, a milder form</p>
            </list-item>
            <list-item>
              <p>Xeroderma pigmentosum-Cockayne syndrome (XP-CS)</p>
            </list-item>
          </list>
          <sec id="cockayne.CS_Type_I">
            <title>CS Type I</title>
            <p>Prenatal growth is typically normal. Birth length, weight, and head circumference are normal. Within the first two years, however, growth and development fall below normal. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability. Severe dental caries occur in up to 86% of individuals. Photosensitivity can be severe, but individuals are not predisposed to skin cancers. </p>
            <p>Additional clinical abnormalities occurring in 10% or more of individuals include the following: </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Neurologic.</bold> Increased tone/spasticity, hyper- or hyporeflexia, abnormal gait or inability to walk, ataxia, incontinence, tremor, abnormal or absent speech, seizures, weak cry/poor feeding (as an infant), muscle atrophy, and behavioral abnormality </p>
              </list-item>
              <list-item>
                <p><bold>Dermatologic.</bold> Anhidrosis and malar rash </p>
              </list-item>
              <list-item>
                <p><bold>Ophthalmologic.</bold> Enophthalmos, pigmentary retinopathy (60%-100%), abnormal electroretinogram, cataracts of various types (15%-36%), optic atrophy, miotic pupils, farsightedness, decreased or absent tears, strabismus, nystagmus, photophobia, narrowed retinal arterioles, and microphthalmia </p>
              </list-item>
              <list-item>
                <p><bold>Dental.</bold> Absent or hypoplastic teeth, delayed eruption of deciduous teeth, and malocclusion </p>
              </list-item>
              <list-item>
                <p><bold>Renal.</bold> Abnormal renal function and pathologic abnormalities; noted in case reports, but usually not clinically significant</p>
              </list-item>
              <list-item>
                <p><bold>Endocrine.</bold> Undescended testes, delayed/absent sexual maturation. No individuals with classic or severe CS (types I or II) have been known to reproduce. A successful (but very difficult) pregnancy has been reported in a young woman with mild CS (type III) [<xref ref-type="bibr" rid="cockayne.REF.lahiri.2003.871">Lahiri &#x00026; Davies 2003</xref>]. </p>
              </list-item>
              <list-item>
                <p><bold>Gastrointestinal.</bold> Elevated liver function tests, enlargement of liver or spleen </p>
              </list-item>
            </list>
            <p>Death typically occurs in the first or second decade. The mean age of death is 12 years, but survival into the third decade has been reported. </p>
          </sec>
          <sec id="cockayne.CS_Type_II">
            <title>CS Type II</title>
            <p>Children with severe CS have evidence of growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye are present in 30%. Affected individuals have arthrogryposis or early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Affected children typically die by age seven years. CS type II overlaps clinically with the cerebrooculofacioskeletal syndrome (COFS), which is also referred to as Pena-Shokeir syndrome type II. </p>
          </sec>
          <sec id="cockayne.CS_Type_III">
            <title>CS Type III</title>
            <p>Recently, DNA sequencing has confirmed the diagnosis of CS type III in some individuals who have clinical features associated with CS but whose growth and/or cognition exceeds the expectations for CS type I [E Neilan, unpublished]. </p>
          </sec>
          <sec id="cockayne.XPCS">
            <title>XP-CS</title>
            <p>Since the discovery of the genes in which mutations underlie CS, it has become evident that the distinctions between genotype, cellular phenotype, and clinical phenotype are not absolute. Xeroderma pigmentosum, a related DNA repair disorder, includes facial freckling and early skin cancers &#x02014; features not found in CS. The DeSanctis-Cacchione variant of XP includes some features of CS (e.g., intellectual disability, spasticity, short stature, and hypogonadism) but does not include skeletal dysplasia, the facial phenotype of CS, or CNS dysmyelination and calcifications. Individuals with an XP clinical phenotype have been seen in association with a CS cellular phenotype and with a mutation in <italic toggle="yes">ERCC6</italic> [<xref ref-type="bibr" rid="cockayne.REF.greenhaw.1992.677">Greenhaw et al 1992</xref>, <xref ref-type="bibr" rid="cockayne.REF.colella.2000.1171">Colella et al 2000</xref>]. Conversely, individuals with clinical features of CS but with XP-like skin cancers have been assigned to the XPB, XPD, and XPG complementation groups based on their biochemical characteristics (the ability to restore normal function to various DNA repair-deficient cell lines) [<xref ref-type="bibr" rid="cockayne.REF.okinaka.1997.107">Okinaka et al 1997</xref>, <xref ref-type="bibr" rid="cockayne.REF.riou.1999.1125">Riou et al 1999</xref>, <xref ref-type="bibr" rid="cockayne.REF.vanhoffen.1999.2898">Van Hoffen et al 1999</xref>]. Individuals with other features of CS, but lacking sun sensitivity, have been reported. <xref ref-type="bibr" rid="cockayne.REF.mallery.1998.77">Mallery et al [1998]</xref> has reported a poor correlation between genotype and phenotype for this group of diseases. </p>
            <p><bold>Neuropathology.</bold> A characteristic "tigroid" pattern of demyelination in the subcortical white matter of the brain and multifocal calcium deposition, with relative preservation of neurons and without senile plaques, amyloid, ubiquitin, or tau deposition, is observed [<xref ref-type="bibr" rid="cockayne.REF.itoh.1999.326">Itoh et al 1999</xref>]. </p>
          </sec>
        </sec>
        <sec id="cockayne.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>There is no correlation between the biochemical defect in UV-mediated DNA repair assays and the clinical severity of the syndrome. The ability to repair oxidative lesions may distinguish individuals with UVSS from those with CS [<xref ref-type="bibr" rid="cockayne.REF.nardo.2009.6209">Nardo et al 2009</xref>]</p>
          <p>Early reports found no obvious genotype-phenotype correlations for mutations in either <italic toggle="yes">ERCC8</italic> or <italic toggle="yes">ERCC6</italic>, suggesting that the clinical variability within the CS spectrum may not be accounted for by gene mutation alone.</p>
          <p>It has been reported that a null mutation of <italic toggle="yes">ERCC6</italic> does not produce CS, but instead produces the mild UV-sensitive syndrome [<xref ref-type="bibr" rid="cockayne.REF.horibata.2004.15410">Horibata et al 2004</xref>]. Thus, the presence of a truncated CSB protein or the presence of a chimeric protein consisting of the first five exons of <italic toggle="yes">ERCC6</italic> and the PGBD3 transposon nested in intron 5 could have a specific deleterious effect [<xref ref-type="bibr" rid="cockayne.REF.newman.2008.e1000031">Newman et al 2008</xref>]. However this hypothesis does not currently account for all cases. </p>
        </sec>
        <sec id="cockayne.Nomenclature">
          <title>Nomenclature</title>
          <p>The term cerebrooculofacioskeletal syndrome (COFS) and its synonym, Pena-Shokeir syndrome type II, have been used to refer to a heterogenous group of disorders characterized by congenital neurogenic arthrogryposis (multiple joint contractures), microcephaly, microphthalmia, and cataracts. The original cases of COFS, described by <xref ref-type="bibr" rid="cockayne.REF.pena.1974.285">Pena &#x00026; Shokeir [1974]</xref> among native Canadian families from Manitoba, have since been shown to be homozygous for a mutation in <italic toggle="yes">ERCC6</italic>. Cells from these individuals show the same deficiency of transcription-coupled DNA nucleotide excision repair (TC-NER) as cells from those with CS. COFS can be regarded as an allelic and prenatal form of CS, partly overlapping with CS type II and including the most severe cases of the CS phenotypic spectrum [<xref ref-type="bibr" rid="cockayne.REF.laugel.2008.564">Laugel et al 2008</xref>].</p>
        </sec>
        <sec id="cockayne.Prevalence">
          <title>Prevalence</title>
          <p>The minimum incidence of CS has been estimated at 2.7 per million births in western Europe; the disease is probably underdiagnosed [<xref ref-type="bibr" rid="cockayne.REF.kleijer.2008.744">Kleijer et al 2008</xref>]. </p>
        </sec>
      </sec>
      <sec id="cockayne.Genetically_Related_Allelic_Dis">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">ERCC6</italic></bold>. Mutations in <italic toggle="yes">ERCC6</italic> have also been identified in individuals with: </p>
        <list list-type="bullet">
          <list-item>
            <p>Cerebrooculofacioskeletal syndrome (COFS), now recognized to be part of the spectrum of Cockayne syndrome [<xref ref-type="bibr" rid="cockayne.REF.meira.2000.1221">Meira et al 2000</xref>]; </p>
          </list-item>
          <list-item>
            <p>DeSanctis-Cacchione variant of <related-object link-type="booklink" source-id="gene" document-id="xp" document-type="chapter">xeroderma pigmentosum</related-object> (XP) [<xref ref-type="bibr" rid="cockayne.REF.colella.2000.1171">Colella et al 2000</xref>]; </p>
          </list-item>
          <list-item>
            <p>UV-sensitive syndrome (UVSS) [<xref ref-type="bibr" rid="cockayne.REF.horibata.2004.15410">Horibata et al 2004</xref>]. </p>
          </list-item>
        </list>
        <p><bold><italic toggle="yes">ERCC8</italic></bold>. No other phenotypes are associated with mutations in <italic toggle="yes">ERCC8</italic>. </p>
      </sec>
      <sec id="cockayne.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of CS depends on the presenting features of the particular individual. Abnormalities that suggest alternative diagnoses include congenital anomalies of the face, limbs, heart, or viscera; recurrent infections (other than otitis media or respiratory infections); metabolic or neurologic crises; hematologic abnormality (e.g., anemia, leukopenia); and cancer of any kind [<xref ref-type="bibr" rid="cockayne.REF.nance.1992.68">Nance &#x00026; Berry 1992</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>Growth failure is seen in chromosomal disorders and endocrine, metabolic, or gastrointestinal disorders, including malnutrition. </p>
          </list-item>
          <list-item>
            <p>Most leukodystrophies are not associated with growth failure, with the possible exception of the connatal form of <related-object link-type="booklink" source-id="gene" document-id="pmd" document-type="chapter">Pelizaeus-Merzbacher disease</related-object>. </p>
          </list-item>
          <list-item>
            <p>The presence of calcifications on brain imaging could suggest congenital infections such as rubella or toxoplasmosis, or disorders of calcium and phosphate metabolism. </p>
          </list-item>
          <list-item>
            <p>If photosensitivity or thinning of the skin and hair are prominent, the differential diagnosis includes <related-object link-type="booklink" source-id="gene" document-id="xp" document-type="chapter">xeroderma pigmentosum</related-object>, <related-object link-type="booklink" source-id="gene" document-id="bloom" document-type="chapter">Bloom syndrome</related-object>, and the "premature aging" syndromes, including <related-object link-type="booklink" source-id="gene" document-id="hgps" document-type="chapter">Hutchinson-Gilford progeria syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="werner" document-type="chapter">Werner syndrome</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="rts" document-type="chapter">Rothmund-Thompson syndrome</related-object>. </p>
          </list-item>
          <list-item>
            <p>The early presence of pigmentary retinopathy could suggest a mitochondrial disorder (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>) or a peroxisomal biogenesis disorder (see <related-object link-type="booklink" source-id="gene" document-id="pbd" document-type="chapter">Peroxisomal Biogenesis Disorder, Zellweger syndrome spectrum</related-object>). </p>
          </list-item>
          <list-item>
            <p>Syndromes with profound growth failure (e.g., <related-object link-type="booklink" source-id="gene" document-id="cdls" document-type="chapter">Cornelia de Lange syndrome</related-object>, Dubowitz syndrome, Hallerman-Streiff syndrome, <related-object link-type="booklink" source-id="gene" document-id="rsts" document-type="chapter">Rubinstein-Taybi syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver syndrome</related-object>, Seckel syndrome, and Wiedemann-Rautenstrauch syndrome) can usually be excluded on the basis of physical appearance. </p>
          </list-item>
          <list-item>
            <p>MICRO syndrome can resemble CS type II/COFS at birth, presenting with microcephaly, microcornea, and cataracts. It differs by the absence of rapidly progressive neurodegeneration and by the presence of normal DNA nucleotide excision repair [<xref ref-type="bibr" rid="cockayne.REF.graham.2004.235">Graham et al 2004</xref>]. </p>
          </list-item>
        </list>
      </sec>
      <sec id="cockayne.Management">
        <title>Management</title>
        <sec id="cockayne.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with Cockayne syndrome (CS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of growth </p>
            </list-item>
            <list-item>
              <p>Developmental assessment </p>
            </list-item>
            <list-item>
              <p>Dental evaluation </p>
            </list-item>
            <list-item>
              <p>Dermatologic evaluations </p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluations (possibly including electroretinogram) </p>
            </list-item>
            <list-item>
              <p>Audiologic evaluation (including audiogram) </p>
            </list-item>
            <list-item>
              <p>Brain MRI </p>
            </list-item>
            <list-item>
              <p>Laboratory studies to assess renal and hepatic function </p>
            </list-item>
            <list-item>
              <p>Testing for diabetes mellitus and disorders of calcium metabolism </p>
            </list-item>
            <list-item>
              <p>Skeletal x-rays to document the presence of skeletal dysplasia </p>
            </list-item>
            <list-item>
              <p>Nerve conduction studies to document the presence of a demyelinating neuropathy </p>
            </list-item>
          </list>
        </sec>
        <sec id="cockayne.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individualized educational program for developmental delay </p>
            </list-item>
            <list-item>
              <p>Physical therapy and assistive devices to maintain ambulation in the presence of gait abnormalities </p>
            </list-item>
            <list-item>
              <p>Feeding gastrostomy tube placement for failure to thrive </p>
            </list-item>
            <list-item>
              <p>Medication for spasticity (baclofen) and tremor (carbidopa-levodopa) if needed </p>
            </list-item>
            <list-item>
              <p>Management of hearing loss </p>
            </list-item>
            <list-item>
              <p>Management of cataracts and other ophthalmologic complications </p>
            </list-item>
            <list-item>
              <p>Use of sunscreens for cutaneous photosensitivity </p>
            </list-item>
            <list-item>
              <p>Use of sunglasses for lens and retina protection </p>
            </list-item>
          </list>
        </sec>
        <sec id="cockayne.Prevention_of_Secondary_Complic">
          <title>Prevention of Secondary Complications</title>
          <p>Recommended measures:</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical therapy to prevent joint contractures </p>
            </list-item>
            <list-item>
              <p>Aggressive dental care to minimize dental caries </p>
            </list-item>
            <list-item>
              <p>Home safety assessments to prevent falls </p>
            </list-item>
          </list>
        </sec>
        <sec id="cockayne.Surveillance">
          <title>Surveillance</title>
          <p>Yearly reassessment for known potential complications (e.g., hypertension; renal or hepatic dysfunction; declining vision and hearing) is appropriate.</p>
        </sec>
        <sec id="cockayne.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Excessive sun exposure should be avoided.</p>
        </sec>
        <sec id="cockayne.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="cockayne.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cockayne.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In pregnant women affected with CS, the limited size of the pelvis and abdomen is the major obstacle to the growth of the fetus and the major threat to the outcome of the pregnancy. Prevention of premature labor and caesarean section under spinal anesthesia are usually needed [<xref ref-type="bibr" rid="cockayne.REF.lahiri.2003.871">Lahiri &#x00026; Davies 2003</xref>, <xref ref-type="bibr" rid="cockayne.REF.rawlinson.2003.297">Rawlinson &#x00026; Webster 2003</xref>].</p>
        </sec>
        <sec id="cockayne.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="cockayne.Other">
          <title>Other</title>
          <p>Growth hormone (GH) levels in individuals with Cockayne syndrome (CS) may be elevated or decreased [<xref ref-type="bibr" rid="cockayne.REF.park.1994.74">Park et al 1994</xref>, <xref ref-type="bibr" rid="cockayne.REF.hamamy.2005.875">Hamamy et al 2005</xref>]. While individuals with CS do not appear to have an increased risk of malignancy (an effect which may be due to simultaneous transcription and cell proliferation deficiency), it is theoretically possible that GH treatment could reverse this compensatory effect and promote tumor growth. Therefore, in the absence of safety and efficacy data, GH treatment cannot be recommended in individuals with CS.</p>
        </sec>
      </sec>
      <sec id="cockayne.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cockayne.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Cockayne syndrome is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="cockayne.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one mutant allele. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of a proband has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. It can safely be assumed that all homozygous individuals will be recognizable as affected within the first few years of life. </p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Reproduction has not been reported in any individual with CS types I or II, but in several women with CS type III. Each offspring of an affected person is an obligate carrier. </p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier. </p>
        </sec>
        <sec id="cockayne.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the disease-causing mutations in the family have been identified. </p>
        </sec>
        <sec id="cockayne.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cockayne.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the disease-causing mutations have been identified in the family, prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis (usually performed at ~15-18 weeks&#x02019; gestation) or chorionic villus sampling (usually performed at ~10-12 weeks&#x02019; gestation). Prenatal diagnosis by DNA repair assay on CVS or amniocytes may also be available in some countries. </p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an optoin for some families in which the disease-causing mutations have been identified.</p>
        </sec>
      </sec>
      <sec id="cockayne.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cockayne.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="cockayne.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The proteins encoded by <italic toggle="yes">ERCC6</italic> and <italic toggle="yes">ERCC8</italic> both play important roles in transcription-coupled nucleotide excision repair (TC-NER), a DNA repair process that preferentially removes UV-induced pyrimidine dimers and other transcription-blocking lesions from the transcribed strands of active genes. A deficiency of TC-NER is sufficient to explain the cutaneous photosensitivity of individuals with CS. It is unlikely, however, to explain the growth failure and neurodegeneration that typify CS. In contrast to CS, most individuals with <related-object link-type="booklink" source-id="gene" document-id="xp" document-type="chapter">xeroderma pigmentosum</related-object> (XP) have normal growth and neurologic function, despite having combined deficiencies of both TC-NER and "global genome nucleotide excision repair" (GG-NER). To explain this apparent paradox, a critical role for the products of <italic toggle="yes">ERCC6</italic> and <italic toggle="yes">ERCC8</italic> outside of TC-NER has been suggested, such as an auxiliary function in transcription and/or in non-NER forms of DNA repair [<xref ref-type="bibr" rid="cockayne.REF.dewaard.2004.7941">de Waard et al 2004</xref>, <xref ref-type="bibr" rid="cockayne.REF.vandenboom.2004.27">van den Boom et al 2004</xref>].</p>
          <p><xref ref-type="table" rid="cockayne.T.summary_of_types_of_pathogeni">Table 2</xref> summarizes the different types of mutations found in each gene according to the latest mutation review [<xref ref-type="bibr" rid="cockayne.REF.laugel.2010.113">Laugel et al 2010</xref>].</p>
          <table-wrap id="cockayne.T.summary_of_types_of_pathogeni" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p>Summary of Types of Pathogenic Mutations in Cockayne Syndrome</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1" headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_1">Gene</th>
                  <th id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" colspan="5" align="left" valign="top" rowspan="1">Mutation Type</th>
                </tr>
                <tr>
                  <th headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">Short insertions or deletions</th>
                  <th headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">Nonsense</th>
                  <th headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_3" align="left" valign="middle" rowspan="1" colspan="1">Missense</th>
                  <th headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_4" align="left" valign="middle" rowspan="1" colspan="1">Splice</th>
                  <th headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2" id="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_5" align="left" valign="middle" rowspan="1" colspan="1">Partial- or whole-gene deletions or duplications</th>
                </tr>
                <tr>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC8</italic>
                  </td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_1" align="left" valign="top" rowspan="1" colspan="1">~15%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_2" align="left" valign="top" rowspan="1" colspan="1">~10%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_3" align="left" valign="top" rowspan="1" colspan="1">~25%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_4" align="left" valign="top" rowspan="1" colspan="1">~30%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_5" align="left" valign="top" rowspan="1" colspan="1">~20%</td>
                </tr>
                <tr>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">
                    <italic toggle="yes">ERCC6</italic>
                  </td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_1" align="left" valign="top" rowspan="1" colspan="1">~30%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_2" align="left" valign="top" rowspan="1" colspan="1">~30%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_3" align="left" valign="top" rowspan="1" colspan="1">~15%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_4" align="left" valign="top" rowspan="1" colspan="1">~20%</td>
                  <td headers="hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_1_2 hd_b_cockayne.T.summary_of_types_of_pathogeni_1_1_2_5" align="left" valign="top" rowspan="1" colspan="1">~5%</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <sec id="cockayne.ERCC8">
            <title><italic toggle="yes">ERCC8</italic>
</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC8</italic> has 12 exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000082.3">NM_000082.3</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cockayne" object-id="cockayne.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Benign allelic variants.</bold>
<xref ref-type="bibr" rid="cockayne.REF.cao.2004.61">Cao et al [2004]</xref> reported a benign allelic variant.</p>
            <p><bold>Pathogenic allelic variants.</bold> Several pathogenic variants in <italic toggle="yes">ERCC8</italic> have been identified, including nonsense mutations, missense mutations, and large, partial-gene deletions [<xref ref-type="bibr" rid="cockayne.REF.henning.1995.555">Henning et al 1995</xref>, <xref ref-type="bibr" rid="cockayne.REF.ren.2003.93">Ren et al 2003</xref>, <xref ref-type="bibr" rid="cockayne.REF.cao.2004.61">Cao et al 2004</xref>]. No single mutation type seems to predominate. Intriguingly, <xref ref-type="bibr" rid="cockayne.REF.komatsu.2004.67">Komatsu et al [2004]</xref> recently reported finding multiple abnormal <italic toggle="yes">ERCC8</italic> mRNA splice variants in an individual with CS, although they were unable to identify the DNA mutations responsible for these mRNA splicing abnormalities. </p>
            <p>The reported pathogenic allelic variants in Cockayne syndrome have been summarized [<xref ref-type="bibr" rid="cockayne.REF.cleaver.1999.9">Cleaver et al 1999</xref>, <xref ref-type="bibr" rid="cockayne.REF.laugel.2010.113">Laugel et al 2010</xref>]. See also <related-object source-id="gene" document-id="cockayne" object-id="cockayne.molgen.TA">Table A</related-object>, <bold>HGMD</bold>.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC8</italic> encodes a 396-amino acid protein (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000073.1">NP_000073.1</ext-link> of 44 kd. It is a WD-repeat protein (tryptophan aspartate-repeats), which interacts with the excision repair protein ERCC-6 and the p44 protein. The p44 protein is a subunit of TFIIH, an RNA polymerase II transcription factor. The proteins encoded by <italic toggle="yes">ERCC8</italic> and <italic toggle="yes">ERCC6</italic> both appear to be involved in transcription-coupled DNA repair, and possibly in other processes [<xref ref-type="bibr" rid="cockayne.REF.dewaard.2004.7941">de Waard et al 2004</xref>]. </p>
            <p><bold>Abnormal gene product.</bold> The pathogenic abnormalities thus far reported in <italic toggle="yes">ERCC8</italic> vary from large, partial deletions of the gene that remove entire exons to missense mutations that alter a single amino acid [<xref ref-type="bibr" rid="cockayne.REF.henning.1995.555">Henning et al 1995</xref>, <xref ref-type="bibr" rid="cockayne.REF.ren.2003.93">Ren et al 2003</xref>, <xref ref-type="bibr" rid="cockayne.REF.cao.2004.61">Cao et al 2004</xref>, <xref ref-type="bibr" rid="cockayne.REF.laugel.2010.113">Laugel et al 2010</xref>]. </p>
          </sec>
          <sec id="cockayne.ERCC6">
            <title><italic toggle="yes">ERCC6</italic>
</title>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">ERCC6</italic> has 21 exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000124.2">NM_000124.2</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cockayne" object-id="cockayne.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold> More than 60 different mutations have been reported in <italic toggle="yes">ERCC6</italic>. Most of these are nonsense or frameshift mutations [<xref ref-type="bibr" rid="cockayne.REF.troelstra.1992.939">Troelstra et al 1992</xref>, <xref ref-type="bibr" rid="cockayne.REF.mallery.1998.77">Mallery et al 1998</xref>, <xref ref-type="bibr" rid="cockayne.REF.colella.1999.935">Colella et al 1999</xref>, <xref ref-type="bibr" rid="cockayne.REF.meira.2000.1221">Meira et al 2000</xref>, <xref ref-type="bibr" rid="cockayne.REF.horibata.2004.15410">Horibata et al 2004</xref>, <xref ref-type="bibr" rid="cockayne.REF.laugel.2010.113">Laugel et al 2010</xref>]. See <related-object source-id="gene" document-id="cockayne" object-id="cockayne.molgen.TA">Table A</related-object>, <bold>HGMD</bold>.</p>
            <p><bold>Normal gene product.</bold>
<italic toggle="yes">ERCC6</italic> encodes a 1493-amino acid protein (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000115.1">NP_000115.1</ext-link>), containing at least seven domains that are conserved in DNA and RNA helicases. This protein appears to enhance the elongation of transcription products by RNA polymerase II, and possibly also RNA polymerases I and III. Both proteins encoded by <italic toggle="yes">ERCC8</italic> and <italic toggle="yes">ERCC6</italic> appear to be involved in transcription-coupled DNA repair [<xref ref-type="bibr" rid="cockayne.REF.licht.2003.1217">Licht et al 2003</xref>, <xref ref-type="bibr" rid="cockayne.REF.vandenboom.2004.27">van den Boom et al 2004</xref>]. </p>
            <p><bold>Abnormal gene product.</bold> A large majority of the pathogenic mutations reported in <italic toggle="yes">ERCC6</italic> are nonsense or frameshift mutations that encode a truncated protein or an unstable protein that decays. This somewhat unusual mutation spectrum suggests that the pathogenic mechanism may not be as simple as a loss of normal functions of the protein encoded by <italic toggle="yes">ERCC6</italic>. Indeed, <xref ref-type="bibr" rid="cockayne.REF.horibata.2004.15410">Horibata et al [2004]</xref> report that in at least one case, a homozygous null mutation of <italic toggle="yes">ERCC6</italic> failed to produce CS, causing instead only the much milder UV-sensitive syndrome.</p>
          </sec>
        </sec>
      </sec>
      <sec id="cockayne.References">
        <title>References</title>
        <sec id="cockayne.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cockayne.Literature_Cited.reflist0">
            <ref id="cockayne.REF.boltshauser.1989.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yalcinkaya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wichmann</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reutter</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prader</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valavanis</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>MRI in Cockayne syndrome type I.</article-title>
                <source>Neuroradiology</source>
                <year>1989</year>
                <volume>31</volume>
                <fpage>276</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">2779780</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.cao.2004.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hegele</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>CKN1 (MIM 216400): mutations in Cockayne syndrome type A and a new common polymorphism.</article-title>
                <source>J Hum Genet</source>
                <year>2004</year>
                <volume>49</volume>
                <fpage>61</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14661080</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.cleaver.1999.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cleaver</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>States</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.</article-title>
                <source>Hum Mutat</source>
                <year>1999</year>
                <volume>14</volume>
                <fpage>9</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10447254</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.colella.2000.1171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum.</article-title>
                <source>Hum Mol Genet</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>1171</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10767341</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.colella.1999.935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallery</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borrone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricci</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruffa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Alterations in the CSB gene in three Italian patients with the severe form of Cockayne syndrome (CS) but without clinical photosensitivity.</article-title>
                <source>Hum Mol Genet</source>
                <year>1999</year>
                <volume>8</volume>
                <fpage>935</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">10196384</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.dewaard.2004.7941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Waard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wit</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andressoo</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Oostrom</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riis</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weimann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulsen</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steeg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Horst</surname>
                    <given-names>GT</given-names>
                  </name>
                </person-group>
                <article-title>Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage.</article-title>
                <source>Mol Cell Biol</source>
                <year>2004</year>
                <volume>24</volume>
                <fpage>7941</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15340056</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.graham.2004.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roeder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>MICRO syndrome: an entity distinct from COFS syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>128A</volume>
                <fpage>235</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">15216543</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.greenhaw.1992.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenhaw</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hebert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duke-Woodside</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecht</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleaver</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horton</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <article-title>Xeroderma pigmentosum and Cockayne syndrome: overlapping clinical and biochemical phenotypes.</article-title>
                <source>Am J Hum Genet</source>
                <year>1992</year>
                <volume>50</volume>
                <fpage>677</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">1372469</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.hamamy.2005.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamamy</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daas</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shegem</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Hadidy</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajlouni</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Cockayne syndrome in 2 siblings.</article-title>
                <source>Saudi Med J</source>
                <year>2005</year>
                <volume>26</volume>
                <fpage>875</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15951889</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.henning.1995.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Henning</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDaniel</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reagan</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legerski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayne</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedberg</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH.</article-title>
                <source>Cell</source>
                <year>1995</year>
                <volume>82</volume>
                <fpage>555</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">7664335</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.horibata.2004.15410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horibata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuraoka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurimasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshimura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichihashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>2004</year>
                <volume>101</volume>
                <fpage>15410</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15486090</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.itoh.1999.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shioda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Neurodegeneration in hereditary nucleotide repair disorders.</article-title>
                <source>Brain Dev</source>
                <year>1999</year>
                <volume>21</volume>
                <fpage>326</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10413020</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.kleijer.2008.744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berneburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratchev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.</article-title>
                <source>DNA Repair (Amst)</source>
                <year>2008</year>
                <volume>7</volume>
                <fpage>744</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18329345</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.komatsu.2004.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Komatsu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inagaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashizume</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>A kindred with Cockayne syndrome caused by multiple splicing variants of the CSA gene.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>128A</volume>
                <fpage>67</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15211661</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.lahiri.2003.871">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lahiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>N.</given-names>
                  </name>
                </person-group>
                <article-title>Cockayne's Syndrome: case report of a successful pregnancy.</article-title>
                <source>BJOG</source>
                <year>2003</year>
                <volume>110</volume>
                <fpage>871</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">14511973</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.laugel.2008.564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalloz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Coignard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin-Garraud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation.</article-title>
                <source>J Med Genet.</source>
                <year>2008</year>
                <volume>45</volume>
                <fpage>564</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18628313</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.laugel.2010.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalloz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauvanaud</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristensen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gener</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Coignard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin-Garraud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Journel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raffo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigneron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murday</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gubser-Mercati</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funalot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez Del Pozo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mu&#x000f1;oz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noruzinia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stark</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fieggen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloch-Zupan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egly</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>113</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">19894250</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.licht.2003.1217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Licht</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevnsner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohr</surname>
                    <given-names>VA</given-names>
                  </name>
                </person-group>
                <article-title>Cockayne syndrome group B cellular and biochemical functions.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2003</year>
                <volume>73</volume>
                <fpage>1217</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">14639525</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.lowry.1982.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lowry</surname>
                    <given-names>RB</given-names>
                  </name>
                </person-group>
                <article-title>Early onset of Cockayne syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <year>1982</year>
                <volume>13</volume>
                <fpage>209</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">7137232</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.mallery.1998.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mallery</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanganelli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steingrimsdottir</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gool</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troelstra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <year>1998</year>
                <volume>62</volume>
                <fpage>77</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">9443879</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.meira.2000.1221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meira</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doughty</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziffer</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savre-Train</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedberg</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <article-title>Manitoba aboriginal kindred with original cerebro-oculo-facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene.</article-title>
                <source>Am J Hum Genet</source>
                <year>2000</year>
                <volume>66</volume>
                <fpage>1221</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10739753</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.nance.1992.68">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Cockayne syndrome: review of 140 cases.</article-title>
                <source>Am J Med Genet</source>
                <year>1992</year>
                <volume>42</volume>
                <fpage>68</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">1308368</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.nardo.2009.6209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oneda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spivak</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orioli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanawalt</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2009</year>
                <volume>106</volume>
                <fpage>6209</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">19329487</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.newman.2008.e1000031">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavelitz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiner</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome.</article-title>
                <source>PLoS Genet.</source>
                <year>2008</year>
                <volume>4</volume>
                <fpage>e1000031</fpage>
                <pub-id pub-id-type="pmid">18369450</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.okinaka.1997.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okinaka</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Castro</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sena</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laubscher</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strniste</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacInnes</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraemer</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Heritable genetic alterations in a xeroderma pigmentosum group G/Cockayne syndrome pedigree.</article-title>
                <source>Mutat Res</source>
                <year>1997</year>
                <volume>385</volume>
                <fpage>107</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">9447232</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.park.1994.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baek</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>DY</given-names>
                  </name>
                </person-group>
                <article-title>Cockayne syndrome: a case with hyperinsulinemia and growth hormone deficiency.</article-title>
                <source>J Korean Med Sci</source>
                <year>1994</year>
                <volume>9</volume>
                <fpage>74</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8068222</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.pena.1974.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pena</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shokeir</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive cerebro-oculo-facio-skeletal (COFS) syndrome.</article-title>
                <source>Clin Genet</source>
                <year>1974</year>
                <volume>5</volume>
                <fpage>285</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">4211825</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.rawlinson.2003.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rawlinson</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>VJ</given-names>
                  </name>
                </person-group>
                <article-title>Spinal anaesthesia for caesarean section in a patient with Cockayne syndrome.</article-title>
                <source>Int J Obstet Anesth.</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>297</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15321464</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.ren.2003.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ren</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saijo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaizumi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Three novel mutations responsible for Cockayne syndrome group A.</article-title>
                <source>Genes Genet Syst</source>
                <year>2003</year>
                <volume>78</volume>
                <fpage>93</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">12655141</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.riou.1999.1125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riou</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevallier-Lagente</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stary</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikaido</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weeda</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mezzina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarasin</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes.</article-title>
                <source>Hum Mol Genet</source>
                <year>1999</year>
                <volume>8</volume>
                <fpage>1125</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10332046</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.stefanini.1996.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stefanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Genetic analysis of twenty-two patients with Cockayne syndrome.</article-title>
                <source>Hum Genet</source>
                <year>1996</year>
                <volume>97</volume>
                <fpage>418</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">8834235</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.sugita.1992.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niimi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Comparison of MRI white matter changes with neuropsychologic impairment in Cockayne syndrome.</article-title>
                <source>Pediatr Neurol</source>
                <year>1992</year>
                <volume>8</volume>
                <fpage>295</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1388420</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.troelstra.1992.939">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Troelstra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Gool</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wit</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bootsma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes.</article-title>
                <source>Cell</source>
                <year>1992</year>
                <volume>71</volume>
                <fpage>939</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">1339317</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.troelstra.1993.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Troelstra</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hesen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bootsma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>Structure and expression of the excision repair gene ERCC6, involved in the human disorder Cockayne's syndrome group B.</article-title>
                <source>Nucleic Acids Res</source>
                <year>1993</year>
                <volume>21</volume>
                <fpage>419</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">8382798</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.vandenboom.2004.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van den Boom</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Citterio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogstraten</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zotter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egly</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Cappellen</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houtsmuller</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>DNA damage stabilizes interaction of CSB with the transcription elongation machinery.</article-title>
                <source>J Cell Biol</source>
                <year>2004</year>
                <volume>166</volume>
                <fpage>27</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15226310</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.vangool.1997.5955">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Gool</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Citterio</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rademakers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Os</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Constantinou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egly</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bootsma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <article-title>The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex.</article-title>
                <source>EMBO J</source>
                <year>1997</year>
                <volume>16</volume>
                <fpage>5955</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">9312053</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.vanhoffen.1999.2898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Hoffen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalle</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jong-Versteeg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Zeeland</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullenders</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <article-title>Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.</article-title>
                <source>Nucleic Acids Res</source>
                <year>1999</year>
                <volume>27</volume>
                <fpage>2898</fpage>
                <lpage>904</lpage>
                <pub-id pub-id-type="pmid">10390531</pub-id>
              </element-citation>
            </ref>
            <ref id="cockayne.REF.venema.1990.4707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Venema</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullenders</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natarajan</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Zeeland</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayne</surname>
                    <given-names>LV</given-names>
                  </name>
                </person-group>
                <article-title>The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>1990</year>
                <volume>87</volume>
                <fpage>4707</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">2352945</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cockayne.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cockayne.Suggested_Reading.reflist0">
            <ref id="cockayne.REF.natale.2011.1081">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Natale</surname>
                    <given-names>V.</given-names>
                  </name>
                </person-group>
                <article-title>A comprehensive description of the severity groups in Cockayne syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>1081</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">21480477</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cockayne.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cockayne.Author_History">
          <title>Author History</title>
          <p>Vincent Laugel, MD, PhD (2012-present)Martha A Nance, MD; Park Nicollet Clinic (2000-2006) Edward G Neilan, MD, PhD; Children&#x02019;s Hospital Boston (2006-2012)</p>
        </sec>
        <sec id="cockayne.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 June 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 March 2006 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>24 September 2003 (cd) Revision: clinical test no longer available </p>
            </list-item>
            <list-item>
              <p>21 August 2003 (cd) Revision: change in gene name </p>
            </list-item>
            <list-item>
              <p>31 July 2003 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>15 October 2001 (mn) Author revision </p>
            </list-item>
            <list-item>
              <p>28 December 2000 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>June 2000 (mn) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
